{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:07:41Z","timestamp":1786370861836,"version":"build-2736575974"},"reference-count":80,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec id=\"j_cclm-2017-1176_s_999\">\n<jats:title id=\"d6352801e79448\">Background<\/jats:title>\n<jats:p>There is no consensus in the medical community about the prognostic role of preoperative serum levels of human epididymis protein 4 (HE4) in ovarian cancer (OC). The purpose of this meta-analysis was to establish whether preoperative serum levels of HE4 are associated with OC prognosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"j_cclm-2017-1176_s_998\">\n<jats:title id=\"d6352801e79457\">Content<\/jats:title>\n<jats:p>Eligible studies were searched for in PubMed, ClinicalTrials.gov, CNKI and Wanfang Med Online. We performed a meta-analysis of 1315 OC cases from 14 published articles.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"j_cclm-2017-1176_s_997\">\n<jats:title id=\"d6352801e79466\">Summary<\/jats:title>\n<jats:p>Our meta-analysis demonstrated that high HE4 was associated with poor overall survival (OS) (random effects model, hazard ratio [HR]=1.91, 95% confidence interval [CI]=1.40\u20132.614, p&lt;0.0001; I<jats:sup>2<\/jats:sup>=52%, p=0.04) and; progression-free survival (PFS) (random effects model, HR=1.38, 95% CI=1.13\u20131.69, p=0.002; I<jats:sup>2<\/jats:sup>=85%, p&lt;0.00001). However, subgroup analysis showed that high HE4 was not associated with poor OS (fixed effects model, HR=1.86, 95% CI=0.89\u20133.89, p=0.1; I<jats:sup>2<\/jats:sup>=34%, p=0.22) or PFS (random effects model, HR=1.34, 95% CI=0.95\u20131.88, p=0.1; I<jats:sup>2<\/jats:sup>=69%, p=0.007) for studies including only Asian populations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"j_cclm-2017-1176_s_996\">\n<jats:title id=\"d6352801e79487\">Outlook<\/jats:title>\n<jats:p>In conclusion, this meta-analysis shows that high HE4 was associated with poor OC OS and PFS overall. However, the association of high HE4 with poor OS and PFS was not observed for Asians. Large-scale, multi-center investigations should be performed.<\/jats:p>\n<\/jats:sec>","DOI":"10.1515\/cclm-2017-1176","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T08:05:29Z","timestamp":1523520329000},"page":"1026-1034","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic value of HE4 in patients with ovarian cancer"],"prefix":"10.1515","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-2139","authenticated-orcid":false,"given":"Cunzhong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref241","first-page":"235","article-title":"Study on the relationship between serum he4 level and prognosis of ovarian epithelial cancer patients","volume":"12","year":"2014","journal-title":"Guide of China Medicine"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.7717\/peerj.1386","article-title":"Overexpression of centromere protein k (cenpk) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance","volume":"3","year":"2015","journal-title":"PeerJ"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","year":"1997","journal-title":"Br Med J"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1245\/s10434-011-1943-5","article-title":"Serum he4 level is an independent prognostic factor in epithelial ovarian cancer","volume":"19","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2012.09.003","article-title":"Human epididymis protein 4 (he4) and ovarian cancer prognosis","volume":"127","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"23862","DOI":"10.18632\/oncotarget.13317","article-title":"Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1245\/s10434-013-3347-1","article-title":"He4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse","volume":"21","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/1471-2407-14-819","article-title":"Microrna-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis","volume":"14","year":"2014","journal-title":"BMC Cancer"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2012.09.003","article-title":"Human epididymis protein 4 (he4) and ovarian cancer prognosis","volume":"127","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"ref191","first-page":"382","article-title":"Human epididymal protein 4 (he4) is a novel biomarker and a promising prognostic factor in ovarian cancer patients","volume":"33","year":"2012","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref551","first-page":"445","article-title":"Expression of serum human epididymis protein 4 in epithelial ovarian cancer and its correlation with prognosis","volume":"36","year":"2013","journal-title":"Chin J Oncol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1757-2215-5-20","article-title":"High preoperative blood levels of he4 predicts poor prognosis in patients with ovarian cancer","volume":"5","year":"2012","journal-title":"J Ovarian Res"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"44281","DOI":"10.1038\/srep44281","article-title":"Prognostic and clinicopathological role of high ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"ref41","first-page":"5642","article-title":"Prognostic and predictive values of nrf2, keap1, p16 and e-cadherin expression in ovarian epithelial carcinoma","volume":"8","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14737140.2017.1360138","article-title":"The role of novel biomarker he4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review","volume":"17","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref441","first-page":"5642","article-title":"Prognostic and predictive values of nrf2, keap1, p16 and e-cadherin expression in ovarian epithelial carcinoma","volume":"8","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387042-1.00001-0","article-title":"He4 in ovarian cancer: from discovery to clinical application","volume":"55","year":"2011","journal-title":"Adv Clin Chem"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1007\/s11033-013-2709-x","article-title":"Analyze association of the progesterone receptor gene polymorphism progins with ovarian cancer risk","volume":"40","year":"2013","journal-title":"Mol Biol Rep"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-11-0635","article-title":"Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management","volume":"20","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.3892\/ol.2016.4533","article-title":"Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer","volume":"11","year":"2016","journal-title":"Oncol Lett"},{"key":"ref331","first-page":"648137","article-title":"Analyzing association of the xrcc3 gene polymorphism with ovarian cancer risk","volume":"2014","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group","volume":"283","year":"2000","journal-title":"Am J Med Assoc"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14737140.2017.1360138","article-title":"The role of novel biomarker he4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review","volume":"17","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/apm.12625","article-title":"He4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer","volume":"124","year":"2016","journal-title":"APMIS"},{"key":"ref151","first-page":"445","article-title":"Expression of serum human epididymis protein 4 in epithelial ovarian cancer and its correlation with prognosis","volume":"36","year":"2013","journal-title":"Chin J Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"62400","DOI":"10.18632\/oncotarget.18253","article-title":"Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/IGC.0b013e31821e052e","article-title":"Prognostic impact of prechemotherapy serum levels of her2, ca125, and he4 in ovarian cancer patients","volume":"21","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"ref541","first-page":"503","article-title":"Correlation between serum he4 and ca125 levels in diagnosis and prognosis of ovarian cancer","volume":"20","year":"2016","journal-title":"The Medical Forum"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"44281","DOI":"10.1038\/srep44281","article-title":"Prognostic and clinicopathological role of high ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.7717\/peerj.1386","article-title":"Overexpression of centromere protein k (cenpk) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance","volume":"3","year":"2015","journal-title":"PeerJ"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/apm.12625","article-title":"He4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer","volume":"124","year":"2016","journal-title":"APMIS"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1757-2215-5-20","article-title":"High preoperative blood levels of he4 predicts poor prognosis in patients with ovarian cancer","volume":"5","year":"2012","journal-title":"J Ovarian Res"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"62400","DOI":"10.18632\/oncotarget.18253","article-title":"Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"ref591","first-page":"382","article-title":"Human epididymal protein 4 (he4) is a novel biomarker and a promising prognostic factor in ovarian cancer patients","volume":"33","year":"2012","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group","volume":"283","year":"2000","journal-title":"Am J Med Assoc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tranon.2015.09.002","article-title":"Sex steroid hormone receptor expression affects ovarian cancer survival","volume":"8","year":"2015","journal-title":"Transl Oncol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.18632\/oncotarget.14173","article-title":"Diagnostic accuracy of urine he4 in patients with ovarian cancer: a meta-analysis","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"ref141","first-page":"503","article-title":"Correlation between serum he4 and ca125 levels in diagnosis and prognosis of ovarian cancer","volume":"20","year":"2016","journal-title":"The Medical Forum"},{"key":"ref521","first-page":"829","article-title":"Analysis of correlation between serum level of ca125 and he4 and severity of ovarian cancer","volume":"17","year":"2013","journal-title":"Chin J Lab Diag"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/14712598.2017.1340935","article-title":"Updates and current challenges in microrna research for personalized medicine in ovarian cancer","volume":"17","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"23862","DOI":"10.18632\/oncotarget.13317","article-title":"Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"ref731","first-page":"648137","article-title":"Analyzing association of the xrcc3 gene polymorphism with ovarian cancer risk","volume":"2014","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj20020869","article-title":"A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein","volume":"368","year":"2002","journal-title":"Biochem J"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","year":"2009","journal-title":"PLoS Med"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","year":"2007","journal-title":"Trials"},{"key":"ref531","first-page":"638","article-title":"The clinical value of serum he4 for prognosis evaluation in patients with ovarian cancer","volume":"21","year":"2012","journal-title":"China Cancer"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/IGC.0b013e31821e052e","article-title":"Prognostic impact of prechemotherapy serum levels of her2, ca125, and he4 in ovarian cancer patients","volume":"21","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.3892\/ol.2016.4533","article-title":"Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer","volume":"11","year":"2016","journal-title":"Oncol Lett"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1245\/s10434-011-1943-5","article-title":"Serum he4 level is an independent prognostic factor in epithelial ovarian cancer","volume":"19","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing he4 and ca125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","year":"2009","journal-title":"Gynecol Oncol"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (he4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","year":"2005","journal-title":"Cancer Res"},{"key":"ref121","first-page":"829","article-title":"Analysis of correlation between serum level of ca125 and he4 and severity of ovarian cancer","volume":"17","year":"2013","journal-title":"Chin J Lab Diag"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1245\/s10434-013-3347-1","article-title":"He4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse","volume":"21","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"276","DOI":"10.21037\/atm.2017.05.13","article-title":"Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective","volume":"5","year":"2017","journal-title":"Ann Transl Med"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387042-1.00001-0","article-title":"He4 in ovarian cancer: from discovery to clinical application","volume":"55","year":"2011","journal-title":"Adv Clin Chem"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1745-6215-14-391","article-title":"Response to: practical methods for incorporating summary time-to-event data into meta-analysis","volume":"14","year":"2013","journal-title":"Trials"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","year":"2009","journal-title":"PLoS Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj20020869","article-title":"A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein","volume":"368","year":"2002","journal-title":"Biochem J"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tranon.2015.09.002","article-title":"Sex steroid hormone receptor expression affects ovarian cancer survival","volume":"8","year":"2015","journal-title":"Transl Oncol"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejogrb.2011.05.021","article-title":"Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer","volume":"158","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/14712598.2017.1340935","article-title":"Updates and current challenges in microrna research for personalized medicine in ovarian cancer","volume":"17","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"276","DOI":"10.21037\/atm.2017.05.13","article-title":"Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective","volume":"5","year":"2017","journal-title":"Ann Transl Med"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","year":"1997","journal-title":"Br Med J"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (he4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","year":"2005","journal-title":"Cancer Res"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-11-0635","article-title":"Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management","volume":"20","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref641","first-page":"235","article-title":"Study on the relationship between serum he4 level and prognosis of ovarian epithelial cancer patients","volume":"12","year":"2014","journal-title":"Guide of China Medicine"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1007\/s11033-013-2709-x","article-title":"Analyze association of the progesterone receptor gene polymorphism progins with ovarian cancer risk","volume":"40","year":"2013","journal-title":"Mol Biol Rep"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejogrb.2011.05.021","article-title":"Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer","volume":"158","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","year":"2007","journal-title":"Trials"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/1471-2407-14-819","article-title":"Microrna-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis","volume":"14","year":"2014","journal-title":"BMC Cancer"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1745-6215-14-391","article-title":"Response to: practical methods for incorporating summary time-to-event data into meta-analysis","volume":"14","year":"2013","journal-title":"Trials"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.18632\/oncotarget.14173","article-title":"Diagnostic accuracy of urine he4 in patients with ovarian cancer: a meta-analysis","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"ref131","first-page":"638","article-title":"The clinical value of serum he4 for prognosis evaluation in patients with ovarian cancer","volume":"21","year":"2012","journal-title":"China Cancer"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing he4 and ca125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2018.56.issue-7\/cclm-2017-1176\/cclm-2017-1176.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-1176\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:54Z","timestamp":1619049654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-1176\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":80,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2017-1176","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,27]]}}}